Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of novel HDAC inhibitors on urothelial carcinoma cells
Aline Kaletsch, Maria Pinkerneil, Michèle J. Hoffmann, et al.
Clinical Epigenetics (2018) Vol. 10, Iss. 1
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Exploiting senescence for the treatment of cancer
Liqin Wang, Lina Lankhorst, René Bernards
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 340-355
Open Access | Times Cited: 513
Senescence and cancer — role and therapeutic opportunities
Clemens A. Schmitt, Boshi Wang, Marco Demaria
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 10, pp. 619-636
Open Access | Times Cited: 442
Senescent Cells in Cancer Therapy: Friends or Foes?
Boshi Wang, Jaskaren Kohli, Marco Demaria
Trends in cancer (2020) Vol. 6, Iss. 10, pp. 838-857
Open Access | Times Cited: 386
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Yue Zhou, Lei Tao, Jiahao Qiu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 141
Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives
Robert Jenke, Nina Reßing, Finn K. Hansen, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 634-634
Open Access | Times Cited: 137
Advances in targeting histone deacetylase for treatment of solid tumors
Mu-Qi Shi, Ying Xu, Xin Fu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 25
HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells
Corrado Caslini, Sunhwa Hong, Yuguang Ban, et al.
Oncogene (2019) Vol. 38, Iss. 39, pp. 6599-6614
Open Access | Times Cited: 100
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
K Freese, Tatjana Seitz, Peter Dietrich, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1587-1587
Open Access | Times Cited: 98
Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
Anna Wawruszak, Joanna Kałafut, Estera Okoń, et al.
Cancers (2019) Vol. 11, Iss. 2, pp. 148-148
Open Access | Times Cited: 90
Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option
Martina Korfei, Poornima Mahavadi, Andreas Guenther
Cells (2022) Vol. 11, Iss. 10, pp. 1626-1626
Open Access | Times Cited: 44
Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications
Binghao Zhao, Bo Wu, Nan Feng, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 25
Inhibition of BET Proteins and Histone Deacetylase (HDACs): Crossing Roads in Cancer Therapy
Gloria Manzotti, Alessia Ciarrocchi, Valentina Sancisi
Cancers (2019) Vol. 11, Iss. 3, pp. 304-304
Open Access | Times Cited: 74
Recent advances in class IIa histone deacetylases research
Yodita Asfaha, Christian Schrenk, Leandro A. Alves Avelar, et al.
Bioorganic & Medicinal Chemistry (2019) Vol. 27, Iss. 22, pp. 115087-115087
Closed Access | Times Cited: 57
Apoptosis Induction byHistone Deacetylase Inhibitors in Cancer Cells: Role of Ku70
Ping Gong, Yuetong Wang, Yongkui Jing
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 7, pp. 1601-1601
Open Access | Times Cited: 56
HDAC5 Loss Impairs RB Repression of Pro-Oncogenic Genes and Confers CDK4/6 Inhibitor Resistance in Cancer
Yingke Zhou, Xin Jin, Jian Ma, et al.
Cancer Research (2021) Vol. 81, Iss. 6, pp. 1486-1499
Open Access | Times Cited: 54
Tumor-Associated Macrophages in Bladder Cancer: Biological Role, Impact on Therapeutic Response and Perspectives for Immunotherapy
M.M. Leblond, Hana Zdimerova, Emma Desponds, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4712-4712
Open Access | Times Cited: 52
MicroRNA Signature in Renal Cell Carcinoma
Soudeh Ghafouri‐Fard, Zeinab Shirvani-Farsani, Wojciech Branicki, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 40
Effect of valproic acid on histone deacetylase expression in oral cancer (Review)
Ahmed S. Al-Khafaji, Lydia M. Wang, Haidar H Alabdei, et al.
Oncology Letters (2024) Vol. 27, Iss. 5
Open Access | Times Cited: 5
Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor Cells
Julia Wanek, Martin Gaisberger, Marlena Beyreis, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3128-3128
Open Access | Times Cited: 44
One-Atom Substitution Enables Direct and Continuous Monitoring of Histone Deacylase Activity
Matthes Zessin, Zsófia Kutil, Marat Meleshin, et al.
Biochemistry (2019) Vol. 58, Iss. 48, pp. 4777-4789
Open Access | Times Cited: 37
Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
Víctor G. Martínez, Ester Munera-Maravilla, Alejandra Bernardini, et al.
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 36
Insights Into the Function and Clinical Application of HDAC5 in Cancer Management
Jun Yang, Chaoju Gong, Qinjian Ke, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 30
Proteomic analysis of the urothelial cancer landscape
Franz F. Dressler, Falk Diedrichs, Deema Sabtan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Histone Deacetylase Inhibitors in the Management of Advanced Cancers
Nicolas Sayegh, Valerie Etzrodt
JCO Precision Oncology (2025), Iss. 9
Closed Access
Advancements in antibody-drug conjugates as cancer therapeutics
Jung Yin Fong, Zhixin Phuna, D. Chong, et al.
Journal of the National Cancer Center (2025)
Open Access
Page 1 - Next Page

Scroll to top